BUFFALO, NY- July 26, 2024 – A new #research paper was #published in Oncotarget's Volume 15 on July 19, 2024, entitled, “Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.”

Macrophage Migration Inhibitory Factor (MIF) and its homolog D-dopachrome Tautomerase (DDT) have been implicated as drivers of tumor progression across a variety of cancers. Recent evidence suggests MIF as a therapeutic target in immune checkpoint inhibition (ICI) resistant melanomas, however clinical evidence of MIF and particularly of DDT remain limited.

In this new retrospective study, researchers Caroline Naomi Valdez, Gabriela Athziri Sánchez-Zuno, Lais Osmani, Wael Ibrahim, Anjela Galan, Antonietta Bacchiocchi, Ruth Halaban, Rajan P. Kulkarni, Insoo Kang, Richard Bucala, and Thuy Tran from Yale University, Oregon Health and Science University, Cancer Early Detection Advanced Research Center (CEDAR), and the Department of Veterans Affairs Portland Health Care System analyzed 97 patients treated at Yale for melanoma between 2002–2020. 

“Our study significantly expands on prior work by De Azevedo et al. by encompassing a larger cohort of individuals, coupled with a comprehensive approach to defining high and low MIF and DDT expression.”

Bulk-RNA sequencing of patient tumor samples from the Skin Cancer SPORE Biorepository was used to evaluate for differential gene expression of MIF, DDT, CD74, and selected inflammatory markers, and gene expression was correlated with patient survival outcomes. Their findings revealed a strong correlation between MIF and DDT levels, with no statistically significant difference across common melanoma mutations and subtypes. 

Improved survival was associated with lower MIF and DDT levels and higher CD74:MIF and CD74:DDT levels. High CD74:DDT and CD74:MIF levels were also associated with enrichment of infiltrating inflammatory cell markers. These data suggest DDT as a novel target in immune therapy. Dual MIF and DDT blockade may provide synergistic responses in patients with melanoma, irrespective of common mutations, and may overcome ICI resistance. These markers may also provide prognostic value for further biomarker development.

“Our study is the first to report survival findings in association with intratumor DDT expression and CD74:DDT expression level ratio. Thus, CD74:MIF and CD74:DDT expression ratio measurements offer promise as prognostic markers for survival outcomes and ICI response in patients with melanoma.”

DOI - https://doi.org/10.18632/oncotarget.28615

Correspondence to - Thuy Tran - thuy.tran@yale.edu

Video short - https://www.youtube.com/watch?v=ULlzscn0PvQ

Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/

Keywords - cancer, MIF, DDT, melanoma, immune checkpoint inhibition, cancer transcriptomics

About Oncotarget 

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:

Facebook - https://www.facebook.com/Oncotarget/
X - https://twitter.com/oncotarget
Instagram - https://www.instagram.com/oncotargetjrnl/
YouTube - https://www.youtube.com/@OncotargetJournal
LinkedIn - https://www.linkedin.com/company/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/user/Oncotarget/
Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh

MEDIA@IMPACTJOURNALS.COM

Oncotarget

Prognostic and Therapeutic Insights Into MIF, DDT, and CD74 in Melanoma

On this episode, Dr. Easley and Bennett Olupo speak with Reverend Robert Jemonde Taylor as he discusses the deep history of Environmental Justice and resilience surrounding Saint Ambrose Episcopal Church's predominantly Black community in Raleigh, North Carolina. He also explains how he draws from a broad range of influences to steward the congregation and land to bring vitality to the community. This episode is rich with hope, history, spirituality, and scientific thought that will brighten up your day and professional practice.

Engineering Grassroots Environmental Justice with Reverend Jamonde Taylor

In this episode, Danna Smith, Dr. Easley, and Bennett Olupo delve into the crucial role of community involvement in protecting and restoring Southern forests. Danna Smith, the founder of The Dogwood Alliance, shares her inspiring journey and the mission to ensure everyone has access to a healthy environment. Her impactful work and the culture of care and determination will leave you feeling empowered to make a positive difference in your community.

Forests for the People and with the People: Danna Smith and the Dogwood Alliance

LSAT expert Laura Damone joins Miriam and Kristi to go over all the nuts and bolts of the LSAT, the most common standardized test utilized in law school admissions.

LSAT Nuts & Bolts

What are the major parts of the LSAT and how should you go about preparing for this test? Your hosts do a dive deep with Laura Damone, who is perhaps the biggest LSAT enthusiast on the planet.

LSAT Deep Dive

Kristi, Miriam, and LSAT expert Laura Damone answer a grab bag of your questions on all things LSAT.

LSAT AMA

Dr. Sharon Chekijian speaks with Dr. Tracy Rabin, the Director of the Office of Global Health at Yale School of Medicine. Dr. Rabin's journey from providing hands-on clinical care in Uganda to establishing sustainable global health education and partnerships has been shaped by her deep commitment to healthcare equity. Explore how her experiences in low-resource settings have inspired her to develop educational frameworks that empower healthcare professionals worldwide and how she envisions the future of global health through collaboration and shared learning.

Building Sustainable Global Health and Bidirectional Partnerships

Father and son Richard and Christopher Hays discuss their new book The Widening of God’s Mercy: Sexuality Within the Biblical Story. This book seeks to take the Bible seriously by taking more of the Bible seriously. These authors do not focus solely on the prooftexts that have been used to deny LGBTQIA+ inclusion in the church, nor do they try to write them off. In this book, New Testament professor Richard Hays and Old Testament professor Christopher Hays provide a fresh map through the Bible that tells the story of a God of mercy and a sexual ethic of inclusion. We talk about their reason for writing this book, the metanoia of Richard’s viewpoint since 1996, some of the passages at play, and what happens next.

32: Sexuality Within the Biblical Story with Richard and Christopher Hays

YDS alumna Vanessa Avery shares lessons learned from decades of interfaith peacebuilding, how architecture can be used as a tool to bring people together, and the importance of radical hospitality.

https://divinity.yale.edu/news/quadcast-sharing-sacred-spaces-and-radical-hospitality-vanessa-avery

Sharing Sacred Spaces and Radical Hospitality with Vanessa Avery

Oncotarget is a primarily oncology-focused, peer-reviewed, open access journal. Papers are published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Oncotarget is now indexed by MEDLINE, PubMed and PMC/PubMed.

Read about the Oncotarget Scientific Integrity Process: https://www.oncotarget.com/scientific_integrity/

Prognostic and Therapeutic Insights Into MIF, DDT, and CD74 in Melanoma

Oncotarget Podcast

Related tracks